Intrasense extends its range of offer to expand its market potential, relying on its strong technological innovation capacity.
Intrasense, Harvard and Zhejiang (China) teaching hospitals are pleased to be finalists for the Galien - MedStartup 2017 Award.
Intrasense announces a new European patent, for invention of a technology facilitating clinician's diagnostic work-up.
Intrasense announces its 2016 results.
Intrasense announces the signature at RSNA of two contracts in the USA and one in the Middle East.
Intrasense announces its presence at RSNA 2016 where it will unveil its new Myrian® 2.0 version.
Intrasense announces its half-year results until June, 30 2016 as approved by the Board of Directors on October 24, 2016.
Intrasense is happy to announce its participation to MedStartup Program 2016, organized by Galien Fundation and Business France.
Intrasense annonces the issuance of a second tranche of "OCABSA" by Bracknor Funds Ltd for a total amount of €1,000,000.
The nomination of Olivier Marrot and Eric Le Bihan as independent board members has been approved during June 28, 2016 shareholders' meeting.
Select your choice...Receive newsGet in touch with the investor serviceOther
By ticking this box, I agree to my data being used by Intrasense to respond to my request and to receive appropriate communications or information. I may withdraw my consent at any time by writing to the Data Protection Officer at dpo@intrasense.fr. For further information, please consult our Privacy Policy.
Please leave this field empty.
En cochant cette case, j'accepte que mes données soient utilisées par Intrasense pour répondre à ma demande et recevoir des communications ou des informations appropriées. Je peux retirer mon consentement à tout moment en écrivant au Délégué à la protection des données à dpo@intrasense.fr. Pour en savoir plus, consultez notre Politique de Confidentialité.
